Consult your health care professional before use if pregnant, nursing, taking medication, or have a medical condition
In T cells, kynurenine induces high PD-1 expression by activating the AhR receptor, promoting the exhaustion of tumor-infiltrating T cells and thereby enabling evasion of immune killing (289)
Molecular Composition and Characteristics Component 1: BPC-157 (synthetic pentadecapeptide) Component 2: TB-500 (thymosin beta-4 analogue) Structure: Linear synthetic peptide chains supplied as a blended formulation Dose Format: High-concentration 20mg blended vial Stability: High under recommended laboratory storage conditions Stability, Handling, and Storage Profile Supplied as a lyophilised powder for optimal long-term stability Recommended storage temperature: 20C Sensitive to moisture, oxygen, and prolonged light exposure Predictable degradation at elevated temperatures Reconstituted solutions typically stable for 2448 hours under refrigeration Solubility and Reconstitution Options Bacteriostatic water Sterile saline solutions Acidic buffer systems Compatible organic analytical solvents Technical Specifications product Name BPC-157 + TB-500 Blend 20mg cas 137525-51-0, 77591-33-4 purity 99% (HPLC verified) unit Size 20 mg blended vial form Lyophilised peptide blend synthesis Solid-Phase Peptide Synthesis (SPPS) analytical HPLC, Mass Spectrometry, UV Spectrophotometry molecular Structure Linear synthetic peptide chains stability High when stored under recommended conditions Analytical Validation and Quality Control HPLC purity confirmation for each peptide component Mass Spectrometry molecular identity verification UV spectrophotometric concentration analysis Batch consistency and reproducibility testing Endotoxin and microbial screening for regulated laboratory use Regulatory Status and Intended Use BPC-157 + TB-500 Blend 20mg is supplied strictly for laboratory research and in-vitro scientific investigation
Prodrug of epigallocatechin-3-gallate alleviates choroidal neovascularization via down-regulating HIF-1/VEGF/VEGFR2 pathway and M1 type macrophage/microglia polarization
Modulating pharmacokinetics, tumor uptake and biodistribution by engineered nanoparticles
Solomon SD, Skali H, Anavekar NS, Bourgoun M, Barvik S, Ghali JK, et al
